Filter Type: All Time (0 Results) Past 24 Hours Past Week Past month Post Your Comments?
All Time (0 Results)
Past 24 Hours
Past Week
Past month
Cartesian operates its wholly-owned, state-of-the-art GMP manufacturing facility in Gaithersburg, MD. Cartesian’s commanding IP position benefits in part from a broad, exclusive patent license from the National Cancer Institute.
Cartesian Therapeutics is a clinical-stage biotechnology company developing novel cellular immunotherapies to cure cancer. Cartesian’s proprietary technology, originally developed by NIH researchers, has the potential to greatly broaden the use of Chimeric Antigen Receptor (CAR) cells for patients with multiple myeloma and other diseases.
Cartesian uses the RNA Armory ®, its proprietary cell therapy platform, to engineer combination therapies into cells, and targets these cells precisely to the site of disease. Cartesian is conducting multiple clinical trials in autoimmune, oncologic, and respiratory disorders.